In today’s rapidly evolving scientific landscape, eliminating barriers to progress is more critical than ever. Precision medicine and targeted therapies hold great promise but are dependent on the ...
– Initial translational results support proof-of-mechanism with immune reprogramming resulting in tumor penetration and pro-inflammatory alteration in the TME – CAMBRIDGE, Mass., May 30, 2025 ...
Cancer cells have softer membranes than healthy cells. New nanoparticles exploit this physical difference to fuse selectively with tumors and deliver mRNA therapy with minimal off-target effects.
Scientists developed a groundbreaking class of mRNA medicines that can sense changes in the body and autonomously adjust their therapeutic effect. The new mRNA medicine works by responding to specific ...
-- Financing oversubscribed; proceeds from the round will be used to expand Strand’s growing mRNA platforms into multiple immuno-oncology and disease settings, and advance lead drug into Phase 1 ...
Osaka, Japan — A research team from The University of Osaka and Institute of Science Tokyo has developed a groundbreaking class of mRNA medicines that can sense changes in the body and autonomously ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results